Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Unlock the True Worth of Your Expertise
New Amplify Your Value Track at AAA 2026 Designed for audiologists and practice leaders, our new Amplify Your Value track empowers you to rethink how…
The Deaflympics Receives Sport and Performance Psychology Support
The Deaflympics will celebrate its 100th birthday this year. It is the second-oldest international sports competition in the world, second only to the Olympics. Sport and performance…
Support for Congenital Cytomegalovirus Screenings
Congenital cytomegalovirus (cCMV) is the number one cause of non-genetic sensorineural hearing loss (SNHL) in children. One in every 3 children is infected by age 5,…


